The Opportunity With obesity increasingly recognized as a chronic medical condition with severe consequences, the growing global obesity management market is projected to reach $352 billion by 2033
Bloodwork every 2 weeks tracks glucose, insulin, and IGF-1
Medicare Part D generally excludes weight loss medications, and Medicaid coverage varies by state
Wegovy contains the same semaglutide molecule at a higher dose of up to 2.4mg, specifically developed and licensed for chronic weight management
These steps can help you manage mild reactions effectively and keep the skin healthy as it heals
Despite their distinct clinical features and underlying pathophysiology, neurodegenerative diseases share fundamental disease processes associated with neuronal dysfunction and death (Wilson et al., 2023